These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9647651)

  • 1. Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization.
    LaJeunesse DR; McCartney BM; Fehon RG
    J Cell Biol; 1998 Jun; 141(7):1589-99. PubMed ID: 9647651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation.
    McCartney BM; Kulikauskas RM; LaJeunesse DR; Fehon RG
    Development; 2000 Mar; 127(6):1315-24. PubMed ID: 10683183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
    Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
    BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM; Kaye AH
    J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct cellular and subcellular patterns of expression imply distinct functions for the Drosophila homologues of moesin and the neurofibromatosis 2 tumor suppressor, merlin.
    McCartney BM; Fehon RG
    J Cell Biol; 1996 May; 133(4):843-52. PubMed ID: 8666669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
    Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
    Stokowski RP; Cox DR
    Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic screen for dominant second-site modifiers of Merlin/NF2 phenotypes reveals an interaction with blistered/DSRF and scribbler.
    LaJeunesse DR; McCartney BM; Fehon RG
    Genetics; 2001 Jun; 158(2):667-79. PubMed ID: 11404331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal absence of merlin, but not other ERM family members, in schwannomas.
    Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
    Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
    Shaw RJ; McClatchey AI; Jacks T
    Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The merlin interacting proteins reveal multiple targets for NF2 therapy.
    Scoles DR
    Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.
    Nguyen R; Reczek D; Bretscher A
    J Biol Chem; 2001 Mar; 276(10):7621-9. PubMed ID: 11106646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.
    Yogesha SD; Sharff AJ; Giovannini M; Bricogne G; Izard T
    Protein Sci; 2011 Dec; 20(12):2113-20. PubMed ID: 22012890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
    Schmucker B; Ballhausen WG; Kressel M
    Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
    Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
    Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
    Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
    Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading.
    Gutmann DH; Sherman L; Seftor L; Haipek C; Hoang Lu K; Hendrix M
    Hum Mol Genet; 1999 Feb; 8(2):267-75. PubMed ID: 9931334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of merlin by protein phosphatase 1-TIMAP and EBP50 in endothelial cells.
    Boratkó A; Péter M; Csortos C
    Int J Biochem Cell Biol; 2017 Jan; 82():10-17. PubMed ID: 27871951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.